Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.39

€1.39

13.010%
0.16
13.010%
€5.35

€5.35

 
12.12.25 / Stuttgart Stock Exchange WKN: A3EMJP / Symbol: LPTX / Name: Leap Therapeutics / Stock / Micro Cap /
Latest predictions
08.12.25
17.14%
buy
€5.35
16.01.25
-51.57%
buy
Your prediction

Leap Therapeutics Inc. Stock

Leap Therapeutics Inc. dominated the market today, gaining €0.16 (13.010%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Leap Therapeutics Inc. stock is not clear.
With a target price of 5 € there is potential for a 259.71% increase which would mean more than doubling the current price of 1.39 € for Leap Therapeutics Inc..
So far the community has only identified positive things for Leap Therapeutics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Leap Therapeutics Inc. in the next few years

Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -51.57%
Target price 5.348
Change
Ends at 16.01.26

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.50 price target on the stock.
Ratings data for LPTX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -87.67%
Target price 5.026
Change
Ends at 13.08.25

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.50 price target on the stock.
Ratings data for LPTX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -85.85%
Target price 7.471
Change
Ends at 28.06.25

Leap Therapeutics, Inc. (NASDAQ: LPTX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $8.00 price target on the stock.
Ratings data for LPTX provided by MarketBeat
Show more